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Abstract
Politics is not the ghost in the machine of global health policy. Conceptually, it makes little sense to argue otherwise, 
while history is replete with examples of individuals and movements engaging politically in global health policy. 
Were one looking for ghosts, a more likely candidate would be democracy, which is currently under attack by a 
new global health technocracy. Civil society movements offer an opportunity to breathe life into a vital, but dying, 
political component of global health policy. 
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Is politics the ‘ghost in the machine’ of policy, ask Bruen and Brugha in a recent Editorial for this journal (1). The answer must surely be no. If politics were the ‘ghost’ and 
policy the ‘machine’, how could they “causally interact” as 
the authors say they do? Gilbert Ryle asked much the same 
question in his critique of Cartesian dualism, accusing 
Descartes of that most heinous of philosophical crimes—the 
category mistake (2). For Ryle, there was no dualism: body 
and mind were essentially the same category of analysis. The 
same is true for politics and policy—they are from the same 
categorical ‘stock’ rather than distinct entities. In this respect, 
the authors are reiterating a contention that has echoed down 
through the decades, that politics and policy are synonymous 
(3). To research health policy is to research politics, and that 
will require an understanding of influence and power: who 
influences policy, how is that influence exercised, and under 
what conditions? (4)
This will come as no surprise to public health activists, who 
have long understood the intimate relationship between 
politics and policy. As if to make the point, Bruen and Brugha 
begin their analysis with an ongoing international health 
governance issue that has excited much political activism, 
namely reform—or rather clarification—of relations between 
the World Health Organization (WHO) and non-state actors. 
WHO Director General Margaret Chan’s assurance that Public 
Interest and Business Interest NGOs (PINGOs and BINGOs) 
will be regarded as distinct entities has mollified some civil 
society global health movements, if not all (5,6). But Milton 
Friedman reminds us why this is unlikely to remain anything 
but a temporary cease fire: “asking a corporation to be socially 
responsible makes no more sense than asking a building to be” 
(7). Those who are cognizant of the limits of transnational 
corporations to socially interact are likely to resist efforts by 
the WHO to participate in consensus-building dialogue with 
corporate ‘partners’ (8). 
The South Africa access to essential medicines cause célèbre 
is another well-documented example of politics in health 
policy. The campaign received international attention in 2001 
when the South African Treatment Action Campaign (TAC) 
successfully sued the South African government for violating 
its constitutional guarantee of access to healthcare services, 
specifically by failing to provide Nevirapine-based Prevention 
of Mother to Child Transmission of HIV (PMTCT) (9,10). In 
a separate case, TAC was also instrumental in resisting efforts 
by the United States’ pharmaceutical industry to pressure the 
South African government not to amend its Medicines Act 
to allow for the issuing of compulsory licences and permit 
parallel imports of pharmaceuticals. While TAC and Doctors 
without Borders ran a concerted campaign of resistance 
against the US Pharmaceutical Manufacturers Association 
(PhRMA), behind the scenes William Clinton and Albert 
Gore were lending their support in order to secure 2 million 
US dollars worth of campaign funding (11). Ultimately, the 
reason why South African women were able to access cheap 
Anti-Retroviral drugs (ARVs) was because two United States 
Democratic Party candidates decided it would enhance their 
chances of electoral victory if they withdrew their support for 
PhRMA’s legal action against the South African government. 
Given the evident symbiosis between politics and health 
policy, one cannot help but wonder whether Bruen and 
Brugha’s principal enquiry has something of the ‘straw man’ 
about it: does anyone actually treat “politics… as distinct from 
policy”? The authors cite past Global Fund Executive Director 
Richard Feachem—“no cautious political operator”—as 
someone quick to describe the Fund as “apolitical” (1). Of 
course, Feachem is being disingenuous. As Bruen and Brugha 
recount, the birth of the Global Fund involved an intense 
period of political ‘horse-trading’ amongst governments and 
international political institutions. 
Missing from the authors’ account, however, is a sense of the 
options available to global policy-makers at the time, and thus 
an appreciation of which ideas were ultimately rejected. One 
particularly significant fault line fell between supporters of 
selective global health provision (i.e. supporters of a Global 
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Fund for a selected number of infectious diseases) and 
supporters of a more comprehensive approach. The WHO 
had initially proposed a broad initiative focused on diseases 
of poverty, but that was quickly narrowed to a set of specific 
diseases. A fund with the broadest mandate—a global fund 
for health—was favoured by the United Kingdom, Italy, 
and Sweden but failed to gain wider support. But good 
ideas die hard, and, in recognition of both the underlying 
social determinants of global ill-health and the profound 
epidemiological transition from communicable to non-
communicable diseases, there have been concerted efforts in 
recent years to breathe new life into the idea of a Global Fund 
for Health broadly defined (12). 
The evident glee displayed by Feachem describing the 
freedom of the Global Fund to make “principled and technical 
decisions” unencumbered by that most-annoying of political 
creations—the demos—is a 21st Century reminder of a highly 
technocratic, but limited, view of democracy that has its roots 
in the competitive elitism of Weber and Schumpeter (13). 
Both Weber and Schumpeter shared “a conception of political 
life in which there was little scope for democratic participation 
and individual or collective development, and where 
whatever scope existed was subject to the threat of constant 
erosion by powerful social forces” (13). Adopting Weber and 
Schumpeter’s descriptive methodology, we might equally 
describe the current system of global health governance 
as one where democratic participation is under threat by 
unaccountable but increasingly powerful social forces. 
The WHO—perhaps the only global health institution 
that still retains the vestige of democracy—is presented as 
the bloated corpse of a new global health architecture. It is 
perceived as a tar pit for innovation and entrepreneurial spirit 
where, as Bruen and Brugha observe, ‘good ideas go to die’. 
The organisation is being outmanoeuvred at every turn by a 
fleet of nimble, “apolitical”, global health partnerships, such as 
the Global Fund and the GAVI Alliance. Meanwhile, the most 
powerful social (yet politically unaccountable) force in global 
health—Philanthropic Foundations—provide seed funding 
for these partnerships, and are major financers of the WHO. 
At least thirty eight foundations provided 18% of WHO’s 
voluntary funding in 2011–12, with just one foundation, the 
Bill and Melinda Gates Foundation donating most of that—
approximately 446 million US dollars (14,15). That is more 
than any other donor except the United States and twenty 
four times more money than the BRICS (Brazil, Russia, India, 
China, and South Africa) economies combined. Voluntary 
contributions to the WHO are “specified”, meaning that they 
can only be spent on the specific health issues or priorities 
of the contributor, limiting the scope for WHO to respond 
effectively to global health emergencies.
Bruen and Brugha are right: the political is an enduring 
feature of global health policy, and thus of policy analysis. 
But should researchers limit their activities to analysis and 
generating evidence, as the authors suggest, or is there scope 
for a broader, and more active, engagement in politics? For 
example, Anthony Costello has recently called on health 
workers to “shout from the rooftops” the message that climate 
change is a health problem (16). A desperate measure perhaps, 
but one that suggests mainstream channels of communication 
are becoming ineffective. Civil society movements such as the 
Peoples Health Movement are actively working to provide a 
new politics of global health that is more active, more direct, 
than the ‘apolitical’ 21st Century global health architecture 
currently being constructed. Democracy, not politics, is 
the real ‘ghost’ in the machine, but through civil society 
movements, it may be possible to counter concerted efforts by 
elite technocrats to de-democratise global health policy. 
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